PTN
PTN
AMEX · Biotechnology

Palatin Technologies Inc

$19.99
-0.66 (-3.20%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -33.6% upside
Low Target $11.80
Average Target $13.27
High Target $20.48
Current Price $19.99
Current
$19.99
Target
$13.27
$11.80 $13.27 avg $20.48
Scenario Analysis
Bear Case
$11.80
-41.0%
Low target
Base Case
$13.27
-33.6%
Avg target
Bull Case
$20.48
+2.5%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$38.72
-48.4% from high
52-Week Low
$1.75
+1,042.3% from low
Target vs 52W High
$13.27
-65.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%